Cardiology News and Research

Latest Cardiology News and Research

Switching ACS patients to Effient therapy reduces Maximum Platelet Aggregation

A study evaluating the level of platelet aggregation achieved after switching from Plavix (clopidogrel) 75 mg once-daily maintenance dosing plus aspirin to Effient(prasugrel) 10 mg once-daily maintenance dosing (MD) in patients with acute coronary syndrome (ACS) was published today in the Journal of the American College of Cardiology.

14 Sep 2010

Repetitive transcranial magnetic stimulation helps to regain motor function in partially paralyzed patients

Stroke patients who were left partially paralysed found that their condition improved after they received a simple and non-invasive method of brain stimulation, according to research in the September issue of the European Journal of Neurology.

14 Sep 2010

St. John Hospital commences enrollment in CONNECT trial for peripheral artery disease

St. John Hospital and Medical Center in Detroit and Avinger, Inc., a medical device company focused on the development of innovative devices to combat peripheral artery disease, announced today the enrollment of the first patient in the CONNECT (Chronic TOtal OcclusioN CrossiNg with thE WildCat CatheTer) clinical trial.

14 Sep 2010

Potassium salt intake can improve blood pressure: Study

An increased intake of 'good' potassium salts could contribute significantly to improving blood pressure at the population level. The favourable effect brought about by potassium is even estimated to be comparable with the blood pressure reduction achievable by halving the intake of 'bad' sodium salts (mostly from table salt).

14 Sep 2010

Advantec announces partnership with Teladoc for telehealth consultations

Advantec, an innovative provider of HR, Payroll and Benefits services to small and mid-sized businesses, announced today a new partnership with Teladoc, the nation's leading provider of telehealth medical consultations.

14 Sep 2010

Complementary medicine to save millions: Report

According to a new report substituting pharmaceutical antidepressants with St John’s Wort could save the health system $50 million a year. This research was conducted by Access Economics for the National Institute of Complementary Medicine (NICM) at the University of Western Sydney. It showed that cost effectiveness of complementary and alternative therapies have the potential to cut costs without compromising patient outcomes.

13 Sep 2010

HealthWyse, Cardiocom partner to integrate patient information into clinical software

HealthWyse, a leading provider of home health and hospice software and services, announced today that it has partnered with Cardiocom, a leader in home telehealth solutions, to seamlessly integrate patient information into HealthWyse's clinical software.

13 Sep 2010

Medtronic launches CareLink Network for Heart Failure

Medtronic, Inc. today introduced the CareLink® Network for Heart Failure, an extension of the world's largest remote implantable cardiac device monitoring system, that will be available this fall for heart failure clinicians.

13 Sep 2010

Study finds antibiotic safe for treatment of stroke and good companion therapy for tPA

An antibiotic appears to be a safe treatment for stroke and a good companion therapy for tPA, the clot buster that is currently the only FDA-approved drug therapy, researchers report.

13 Sep 2010

First US implantation of Medtronic Tri-Ad Semi-Flexible Tricuspid Annuloplasty Ring

David H. Adams, MD, Marie-Jos-e and Henry R. Kravis Professor and Chairman of the Department of Cardiothoracic Surgery at The Mount Sinai Medical Center, has performed the first implantation of the Medtronic Tri-Ad Semi-Flexible Tricuspid Annuloplasty Ring in the United States. Dr. Adams invented the ring, which was recently approved by the Food and Drug Administration.

13 Sep 2010

Merit Medical Systems acquires BioSphere Medical

Merit Medical Systems, Inc. today announced the completion of its acquisition of BioSphere Medical, Inc., a leading developer and marketer of embolotherapeutic products for the treatment of uterine fibroids, hypervascularized tumors, and arteriovenous malformations.

13 Sep 2010

Ticagrelor exhibits potential for prevention of heart attacks

New findings from a major drug trial have brought experts a step closer to developing a drug which could prevent thousands of British deaths from heart attacks.

13 Sep 2010

Defibtech receives Health Canada approval for Lifeline View AED device

Defibtech, LLC, a leading innovator in the Automated External Defibrillation (AED) market, today announced that it has received approval from Health Canada to market the Lifeline View™ AED device. The Lifeline View AED is the first and only AED to offer a full-color interactive display that shows users step-by-step how to perform CPR and external defibrillation.

13 Sep 2010

Relypsa completes $70M Series B financing

Relypsa, Inc., a biopharmaceutical company developing non-absorbed polymeric drugs, today announced the completion of a Series B financing totaling $70 million. OrbiMed Advisors, LLC, led the financing with participation from existing Relypsa investors New Leaf Venture Partners, 5AM Ventures, Delphi Ventures, Sprout Group and Mediphase Venture Partners.

13 Sep 2010

Cytori Therapeutics releases schedule of fall 2010 and investor conferences

Cytori Therapeutics announced today its fall 2010 conference schedule.

13 Sep 2010

Positron announces opening of Clinical and Technical Cardiovascular PET Training Institute

Positron Corporation, a molecular imaging company specializing in Nuclear Cardiology and a leader in Cardiac PET, announced today the grand opening of its Clinical and Technical Cardiovascular PET Training Institute in Niagara Falls, NY.

13 Sep 2010

Scientists to present preclinical pharmacology data on TRV120027 at Heart Failure Society of America Meeting

Trevena Inc., the leader in the discovery and development of G-protein coupled receptor biased ligands, today announced that its scientists are presenting two posters featuring compelling preclinical pharmacology data on TRV120027 at the 14th Annual Heart Failure Society of America Meeting being held September 12-15, 2010 in San Diego.

13 Sep 2010

Heart Failure Society of America's 14th Annual Scientific Meeting convenes September 12, 2010

The Heart Failure Society of America (HFSA) 14th Annual Scientific Meeting convened Sunday, September 12, 2010 at the San Diego Convention Center in San Diego. This four-day meeting -- a forum for heart failure specialists to present research findings and advances in treatment -- will address emerging trends in research and new developments in the approach to treating patients with all stages of heart failure.

13 Sep 2010

Genes behind aggregation of arsenic in plants

In many countries arsenic in food is a major problem. But researchers at the University of Skövde in Sweden have now identified two genes that may play a crucial role in how arsenic is stored in plants.

13 Sep 2010

Athersys signs agreement with RTI Biologics for MAPC technology access

RTI Biologics Inc., a leading provider of orthopedic and other biologic implants, and Athersys Inc. a leader in regenerative medicine and cell therapy research and development, announced today an agreement under which Athersys will provide RTI access to its Multipotent Adult Progenitor Cell (MAPC) technologies.

13 Sep 2010

Cardiology News and Research

Latest Cardiology News and Research

Switching ACS patients to Effient therapy reduces Maximum Platelet Aggregation

Repetitive transcranial magnetic stimulation helps to regain motor function in partially paralyzed patients

St. John Hospital commences enrollment in CONNECT trial for peripheral artery disease

Potassium salt intake can improve blood pressure: Study

Advantec announces partnership with Teladoc for telehealth consultations

Complementary medicine to save millions: Report

HealthWyse, Cardiocom partner to integrate patient information into clinical software

Medtronic launches CareLink Network for Heart Failure

Study finds antibiotic safe for treatment of stroke and good companion therapy for tPA

First US implantation of Medtronic Tri-Ad Semi-Flexible Tricuspid Annuloplasty Ring

Merit Medical Systems acquires BioSphere Medical

Ticagrelor exhibits potential for prevention of heart attacks

Defibtech receives Health Canada approval for Lifeline View AED device

Relypsa completes $70M Series B financing

Cytori Therapeutics releases schedule of fall 2010 and investor conferences

Positron announces opening of Clinical and Technical Cardiovascular PET Training Institute

Scientists to present preclinical pharmacology data on TRV120027 at Heart Failure Society of America Meeting

Heart Failure Society of America's 14th Annual Scientific Meeting convenes September 12, 2010

Genes behind aggregation of arsenic in plants

Athersys signs agreement with RTI Biologics for MAPC technology access

How agentic AI is reshaping laboratory workflows

Fourier 80: bringing benchtop NMR systems to the laboratory

How industrial hygiene flow calibration supports defensible exposure data

Cardiology News and Research

Latest Cardiology News and Research

How agentic AI is reshaping laboratory workflows

Fourier 80: bringing benchtop NMR systems to the laboratory

How industrial hygiene flow calibration supports defensible exposure data

Newsletters you may be interested in